drugset / Trial / NCT01616290

Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

NCT01616290 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if it is safe and feasible to apply PRT-201 to the adventitia of arteries following successful angioplasty (PTA).

Timeline

Start
2012-10
Primary completion
2014-06
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject vonapanitase Protein / enzyme biologic 0.03 mg Other
Subject vonapanitase Protein / enzyme biologic 1 mg Other
Subject vonapanitase Protein / enzyme biologic 3 mg Other